CQ1373 Preis auf Anfrage

Artikelnummer: TGM-T205249
Artikelname: CQ1373 Preis auf Anfrage
Artikelnummer: TGM-T205249
Hersteller Artikelnummer: T205249
Alternativnummer: TGM-T205249-10MG,TGM-T205249-50MG
Hersteller: TargetMol
Kategorie: Biochemikalien
CQ1373 is a potent RET inhibitor that demonstrates cellular activity against BaF3 cells expressing CCDC6-RET, CCDC6-RET-G810C, and CCDC6-RET-G810R, with IC50 values of 13.0, 25.7, and 28.4 nM, respectively. It shows excellent selectivity for wild-type RET and solvent front mutants G810C/R, with IC50 values of 4.2, 7.1, and 32.4 nM. CQ1373 inhibits RET phosphorylation and downstream signaling through SHC. Additionally, it induces apoptosis (Apoptosis) and cell cycle arrest in BaF3 cells. CQ1373 possesses antitumor efficacy, making it a candidate for cancer research.
Molekulargewicht: 546.93
Formel: C25H22ClF3N6O3
Target-Kategorie: Apoptosis|||c-RET
T205249